354 related articles for article (PubMed ID: 34432543)
1. Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications.
Holdman R; Vigil D; Robinson K; Shah P; Contreras AE
Cannabis Cannabinoid Res; 2022 Aug; 7(4):451-463. PubMed ID: 34432543
[No Abstract] [Full Text] [Related]
2. Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study.
Aran A; Cassuto H; Lubotzky A; Wattad N; Hazan E
J Autism Dev Disord; 2019 Mar; 49(3):1284-1288. PubMed ID: 30382443
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.
Poleg S; Golubchik P; Offen D; Weizman A
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():90-96. PubMed ID: 30171992
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial.
Silva EAD; Medeiros WMB; Santos JPMD; Sousa JMM; Costa FBD; Pontes KM; Borges TC; Espínola C; Andrade E Silva AH; Nunes ELG; Alves NT; Rosa MDD; Albuquerque KLGD
Trends Psychiatry Psychother; 2024; 46():e20210396. PubMed ID: 35617670
[TBL] [Abstract][Full Text] [Related]
5. Current state of evidence of cannabis utilization for treatment of autism spectrum disorders.
Agarwal R; Burke SL; Maddux M
BMC Psychiatry; 2019 Oct; 19(1):328. PubMed ID: 31664964
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid treatment for the symptoms of autism spectrum disorder.
Aran A; Cayam Rand D
Expert Opin Emerg Drugs; 2024 Mar; 29(1):65-79. PubMed ID: 38226593
[TBL] [Abstract][Full Text] [Related]
7. Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.
Siani-Rose M; Cox S; Goldstein B; Abrams D; Taylor M; Kurek I
Cannabis Cannabinoid Res; 2023 Feb; 8(1):126-137. PubMed ID: 34874191
[No Abstract] [Full Text] [Related]
8. Cannabis-based medicines for chronic neuropathic pain in adults.
Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
[TBL] [Abstract][Full Text] [Related]
9. Medicinal cannabis in children and adolescents with autism spectrum disorder: A scoping review.
Fletcher S; Pawliuk C; Ip A; Huh L; Rassekh SR; Oberlander TF; Siden H
Child Care Health Dev; 2022 Jan; 48(1):33-44. PubMed ID: 34403168
[TBL] [Abstract][Full Text] [Related]
10. Recent Updates in Psychopharmacology for the Core and Associated Symptoms of Autism Spectrum Disorder.
Thom RP; Pereira JA; Sipsock D; McDougle CJ
Curr Psychiatry Rep; 2021 Oct; 23(12):79. PubMed ID: 34643815
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
Pedrazzi JFC; Ferreira FR; Silva-Amaral D; Lima DA; Hallak JEC; Zuardi AW; Del-Bel EA; Guimarães FS; Costa KCM; Campos AC; Crippa ACS; Crippa JAS
Psychopharmacology (Berl); 2022 Sep; 239(9):2713-2734. PubMed ID: 35904579
[TBL] [Abstract][Full Text] [Related]
12. The Potential of Salivary Lipid-Based Cannabis-Responsive Biomarkers to Evaluate Medical Cannabis Treatment in Children with Autism Spectrum Disorder.
Siani-Rose M; McKee R; Cox S; Goldstein B; Abrams D; Taylor M; Kurek I
Cannabis Cannabinoid Res; 2023 Aug; 8(4):642-656. PubMed ID: 35343818
[No Abstract] [Full Text] [Related]
13. Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy.
Bar-Lev Schleider L; Mechoulam R; Saban N; Meiri G; Novack V
Sci Rep; 2019 Jan; 9(1):200. PubMed ID: 30655581
[TBL] [Abstract][Full Text] [Related]
14. Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder.
Al-Soleiti M; Balaj K; Thom RP; McDougle CJ; Keary CJ
J Autism Dev Disord; 2022 Sep; 52(9):4164-4171. PubMed ID: 34505186
[TBL] [Abstract][Full Text] [Related]
15. Multiple Antipsychotic Medication Use in Autism Spectrum Disorder.
Wink LK; Pedapati EV; Horn PS; McDougle CJ; Erickson CA
J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):91-94. PubMed ID: 26465194
[TBL] [Abstract][Full Text] [Related]
16. The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present.
Persico AM; Ricciardello A; Lamberti M; Turriziani L; Cucinotta F; Brogna C; Vitiello B; Arango C
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110326. PubMed ID: 33857522
[TBL] [Abstract][Full Text] [Related]
17. Autism Spectrum Disorder and Medical Cannabis: Review and Clinical Experience.
Mostafavi M; Gaitanis J
Semin Pediatr Neurol; 2020 Oct; 35():100833. PubMed ID: 32892960
[TBL] [Abstract][Full Text] [Related]
18. CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature.
Bilge S; Ekici B
J Cannabis Res; 2021 Dec; 3(1):53. PubMed ID: 34911567
[TBL] [Abstract][Full Text] [Related]
19. Medical Cannabis in Children.
Aran A; Cayam-Rand D
Rambam Maimonides Med J; 2020 Jan; 11(1):. PubMed ID: 32017680
[TBL] [Abstract][Full Text] [Related]
20. Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety.
Stolar O; Hazan A; Vissoker RE; Kishk IA; Barchel D; Lezinger M; Dagan A; Treves N; Meiri D; Berkovitch M; Kohn E; Heyman E
Front Pharmacol; 2022; 13():977484. PubMed ID: 36249785
[No Abstract] [Full Text] [Related]
[Next] [New Search]
